Immunotherapy for adrenocortical cancer
References (7)
- et al.
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab
Semin Oncol
(2018) - et al.
Practical considerations in the evaluation and management of adrenocortical cancer
Semin Oncol
(2010) - et al.
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Lancet Oncol
(2015)
There are more references available in the full text version of this article.
Cited by (2)
The role of immune checkpoint inhibitor therapy in advanced adrenocortical carcinoma revisited: review of literature
2020, Journal of Endocrinological Investigation
© 2019 Published by Elsevier Inc.